Innospec Inc.NASDAQ: IOSP

Innospec Reports Second Quarter 2026 Financial Results

· Issued by Innospec Inc. via GlobeNewswire

Summary by 6ix AI

Innospec, a specialty chemicals company, reported total revenues of $491.4 million for the second quarter ended June 30, 2026, up 12 percent from $439.7 million a year earlier. Net income attributable to Innospec was $30.8 million, or $1.25 per diluted share, compared with $23.5 million, or 94 cents per diluted share, in the second quarter last year.

Key details

  • Excluding special items such as foreign currency exchange gains and losses and legacy costs of closed operations, adjusted earnings per share were $1.27 per diluted share, compared with $1.26 a year ago. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, with further adjustments) was $50.1 million, compared with $49.1 million.
  • Performance Chemicals revenues were $190.3 million, up 9 percent, with operating income of $16.4 million, up 15 percent. Fuel Specialties revenues were $185.7 million, up 12 percent, with operating income of $36.3 million, up 3 percent.
  • Oilfield Services revenues were $115.4 million, up 14 percent, with operating income of $8.7 million, up 40 percent from $6.2 million.
  • Cash from operating activities was $7.2 million for the quarter, before capital expenditure of $16.5 million. As of June 30, 2026, Innospec had $250.2 million in cash and cash equivalents and no debt.
  • In the quarter, Innospec paid its semi-annual dividend of 92 cents per common share at a cost of $22.7 million and repurchased 87,089 of its common shares for $6.4 million.

What’s still pending

  • Chief Executive Patrick S. Williams said the company expects further improvement in Performance Chemicals and further sequential improvement in Oilfield Services in the second half of 2026.
  • He also said the company expects increased operating cash flow in the second half as it improves working capital efficiency.

6ix AI wrote this summary from the release below and checked it against the release.

Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent

Continued strength in Fuel Specialties and further improvement in Performance Chemicals and Oilfield Services

Debt-free balance sheet with over $250 million in net cash; $6.4 million in share repurchases

GAAP EPS $1.25 and adjusted non-GAAP EPS $1.27

ENGLEWOOD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the second quarter ended June 30, 2026.

Total revenues for the second quarter were $491.4 million, an increase of 12 percent from $439.7 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $30.8 million or $1.25 per diluted share compared to $23.5 million or 94 cents per diluted share recorded in the second quarter last year. Adjusted EBITDA for the quarter was $50.1 million compared to $49.1 million reported in the same period a year ago.

Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the second quarter was $1.27 per diluted share, compared to $1.26 per diluted share a year ago.

Cash from operating activities was $7.2 million before capital expenditure of $16.5 million. The quarter closed with net cash of $250.2 million. In the second quarter, the Company paid its semi-annual dividend of 92 cents per common share and repurchased 87,089 of its common shares under the share repurchase program at a cost of $22.7 million and $6.4 million respectively.

Adjusted EBITDA and net income attributable to Innospec excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

Quarter ended June 30, 2026Quarter ended June 30, 2025
(in millions, except share and per share data)Net income attributable to InnospecDiluted EPSNet income attributable to InnospecDiluted EPS
Reported GAAP amounts$30.8$1.25$23.5$0.94
Foreign currency exchange (gains)/losses(0.9)(0.04)3.50.14
Amortization of acquired intangible assets0.80.031.60.06
Legacy costs of closed operations0.70.032.30.09
Adjustment to fair value of contingent consideration0.1-0.80.03
0.70.028.20.32
Adjusted non-GAAP amounts$31.5$1.27$31.7$1.26

Commenting on the second quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

“This was a strong quarter for Innospec with all businesses contributing to double digit operating income growth.

Performance Chemicals operating leverage drove a 15 percent operating income increase over last year. In North Carolina we continue to advance our plant repairs, process improvements and upgrades to meet customer requirements. In parallel, we continue to execute on a range of other topline and margin opportunities identified in the business. We expect these combined efforts to drive further improvement in the second half of 2026.

Fuel Specialties had another strong quarter delivering revenue and operating income growth with margins that remained within our target range. As expected, the business continued to deliver consistently as our team advances on a broad set of regional and end-market opportunities in traditional fuel, renewable fuel and non-fuel applications.

Oilfield Services operating income and margins improved sequentially and on the prior year, driven by our recent DRA plant expansion and growing opportunities to deliver this industry-leading technology to our customers. In addition, we remain focused on driving growth and margin improvement in our US and Middle East completions and production business. We are confident that these combined efforts will drive further sequential improvement in the second half of 2026.”

Revenues in Performance Chemicals of $190.3 million were up 9 percent from $173.8 million in the second quarter of last year. Volume reductions of 2 percent were offset by a positive price/mix of 8 percent and a positive currency impact of 3 percent. Gross margins of 17.3 percent decreased by 0.2 percentage points from the same quarter last year. Operating income of $16.4 million increased 15 percent from $14.3 million in the corresponding prior year period.

Revenues in Fuel Specialties of $185.7 million were up 12 percent from $165.1 million in the second quarter of last year. Volumes were up 7 percent with price/mix up 3 percent and a positive currency impact of 2 percent. Gross margins of 36.6 percent decreased by 1.5 percentage points over last year. Operating income of $36.3 million increased 3 percent from $35.4 million a year ago.

Revenues in Oilfield Services of $115.4 million for the quarter were up 14 percent from $100.8 million in the second quarter of last year. Gross margins of 32.3 percent increased by 2.7 percentage points from the same quarter last year. Operating income of $8.7 million increased 40 percent from $6.2 million in the prior year period.

Corporate costs for the quarter were $21.6 million compared with $20.9 million a year ago.

The effective tax rate for the quarter was 25.0 percent compared to 26.0 percent in the same period last year, reflecting the geographical location of taxable profits.

For the quarter, cash provided by operating activities was $7.2 million compared to $10.5 million a year ago. As of June 30, 2026, Innospec had $250.2 million in cash and cash equivalents and no debt.

Mr. Williams concluded,

“This was a strong quarter for Innospec driven by improved performance in all our businesses. We remain focused on further technology development, topline growth and margin improvement opportunities, and we are optimistic about the impact that these actions will have on future results.

Operating cash generation was positive in the quarter, and our net cash position closed at over $250 million. We expect increased operating cash flow in the second half as we improve working capital efficiency. We continue to have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter we continued our record of returning value to shareholders with our semi-annual dividend of 92 cents per share and $6.4 million in share repurchases.”

Use of Non-GAAP Financial Measures

The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, net income attributable to Innospec excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income attributable to Innospec per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange (gains)/losses, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net income attributable to Innospec and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of foreign currency exchange (gains)/losses, amortization of acquired intangible assets, legacy costs of closed operations and adjustment to fair value of contingent consideration. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below.

The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income attributable to Innospec excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income attributable to Innospec) to allocate resources and evaluate the performance of the Company’s operations and has provided a reconciliation of adjusted EBITDA and net income attributable to Innospec excluding special items, and related per share amounts, to GAAP net income attributable to Innospec herein and in the schedules below.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Corbin Barnes
Innospec Inc.
+1-303-792-5554
corbin.barnes@innospecinc.com

INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Schedule 1
(in millions, except share and per share data)Three Months Ended
June 30
Six Months Ended June 30
2026202520262025
Net sales$491.4$439.7$944.6$880.5
Cost of goods sold(353.1)(316.5)(682.8)(632.2)
Gross profit138.3123.2261.8248.3
Operating expenses:
Selling, general and administrative(84.3)(74.6)(162.8)(143.9)
Research and development(14.2)(13.6)(27.4)(26.3)
Adjustment to fair value of contingent consideration(0.1)(0.8)4.6(1.5)
Profit on disposal of property, plant and equipment-0.1-0.2
Total operating expenses(98.6)(88.9)(185.6)(171.5)
Operating income39.734.376.276.8
Other income/(expense), net1.1(4.7)3.7(4.4)
Interest income, net0.82.71.65.1
Income before income taxes41.632.381.577.5
Income taxes(10.4)(8.4)(19.5)(20.0)
Net income31.223.962.057.5
Net income attributable to non-controlling interests(0.4)(0.4)(0.8)(1.2)
Net income attributable to Innospec$30.8$23.5$61.2$56.3
Earnings per share:
Basic$1.25$0.94$2.48$2.26
Diluted$1.25$0.94$2.47$2.24
Weighted average shares outstanding (in thousands):
Basic24,64424,93724,71024,954
Diluted24,70725,04224,80725,097
INNOSPEC INC. AND SUBSIDIARIES
Schedule 2A
SEGMENTAL ANALYSIS OF RESULTSThree Months Ended June 30Six Months Ended June 30
(in millions)2026202520262025
Net sales:
Performance Chemicals$190.3$173.8$359.7$342.2
Fuel Specialties185.7165.1367.3335.4
Oilfield Services115.4100.8217.6202.9
491.4439.7944.6880.5
Gross profit:
Performance Chemicals33.030.561.465.8
Fuel Specialties68.062.9132.3123.7
Oilfield Services37.329.868.158.8
138.3123.2261.8248.3
Operating income:
Performance Chemicals16.414.327.134.1
Fuel Specialties36.335.474.172.3
Oilfield Services8.76.214.310.3
Corporate costs(21.6)(20.9)(43.9)(38.6)
39.835.071.678.1
Adjustment to fair value of contingent consideration(0.1)(0.8)4.6(1.5)
Profit on disposal of property, plant and equipment-0.1-0.2
Total operating income$39.7$34.3$76.2$76.8
Schedule 2B
NON-GAAP MEASURESThree Months Ended June 30Six Months Ended June 30
(in millions)2026202520262025
Net income attributable to Innospec$30.8$23.5$61.2$56.3
Interest income, net(0.8)(2.7)(1.6)(5.1)
Income taxes10.48.419.520.0
Depreciation and amortization9.911.419.822.3
Foreign currency exchange (gains)/losses(1.2)4.7(3.7)4.3
Legacy costs of closed operations0.93.03.23.8
Adjustment to fair value of contingent consideration0.10.8(4.6)1.5
Adjusted EBITDA$50.1$49.1$93.8$103.1
INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
Schedule 3
(in millions)June 30,
2026
December 31,
2025
Assets
Current assets:
Cash and cash equivalents$250.2$292.5
Trade and other accounts receivable408.6342.3
Inventories337.3329.3
Prepaid expenses13.320.1
Prepaid income taxes5.713.1
Other current assets9.67.3
Total current assets1,024.71,004.6
Net property, plant and equipment293.3286.1
Operating lease right-of-use assets47.952.7
Goodwill398.2399.0
Other intangible assets65.367.7
Deferred tax assets13.313.6
Other non-current assets3.58.7
Total assets$1,846.2$1,832.4
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$169.4$174.7
Accrued liabilities170.0152.3
Current portion of operating lease liabilities14.315.9
Current portion of plant closure provisions4.94.9
Current portion of acquisition-related contingent consideration2.87.0
Accrued income taxes6.75.3
Total current liabilities368.1360.1
Operating lease liabilities, net of current portion33.636.8
Plant closure provisions, net of current portion59.860.2
Deferred tax liabilities16.019.1
Pension liabilities and post-employment benefits12.713.2
Acquisition-related contingent consideration, net of current portion1.31.3
Other non-current liabilities3.78.8
Equity1,351.01,332.9
Total liabilities and equity$1,846.2$1,832.4
INNOSPEC INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Schedule 4
Six Months Ended
June 30
(in millions)20262025
Cash Flows from Operating Activities
Net income$62.0$57.5
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization19.922.0
Adjustment to fair value of contingent consideration(4.6)1.5
Deferred taxes(2.7)(0.6)
Profit on disposal of property, plant and equipment-(0.2)
Movements on defined benefit pension plans0.12.6
Stock option compensation3.84.1
Changes in working capital(60.9)(22.6)
Movements in plant closure provisions1.11.4
Movements in income taxes7.2(22.9)
Movements in other assets and liabilities(1.1)(4.0)
Net cash provided by operating activities24.838.8
Cash Flows from Investing Activities
Capital expenditures(26.6)(21.4)
Proceeds on disposal of property, plant and equipment1.50.5
Internally developed software(5.1)(10.8)
Net cash used in investing activities(30.2)(31.7)
Cash Flows from Financing Activities
Dividend paid(22.7)(20.8)
Issue of treasury stock0.10.4
Repurchase of common stock(13.5)(13.3)
Net cash used in financing activities(36.1)(33.7)
Effect of foreign currency exchange rate changes on cash(0.8)4.0
Net change in cash and cash equivalents(42.3)(22.6)
Cash and cash equivalents at beginning of period292.5289.2
Cash and cash equivalents at end of period$250.2$266.6

Innospec Inc. on 6ix

Story so far

Earlier from Innospec

Later from Innospec

All Innospec news releases